ModivCare
Stock Forecast, Prediction & Price Target
ModivCare Financial Estimates
ModivCare Revenue Estimates
ModivCare EBITDA Estimates
ModivCare Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | ||
Revenue
% change YoY
| $1.99B N/A | $2.50B 25.41% | $2.75B 9.85% | Avg: $3.04B Low: $3.03B High: $3.05B avg. 10.85% | Avg: $3.23B Low: $3.20B High: $3.27B avg. 5.98% | ||
Net Income
% change YoY
| $31.96M N/A | $-1.84M -105.76% | $-204.46M -10999.89% | Avg: $16.32M Low: $-4.96M High: $17.57M avg. 107.98% | Avg: $24.33M Low: $13.60M High: $32.74M avg. 49.00% | ||
EBITDA
% change YoY
| $146.76M N/A | $157.49M 7.31% | $-26.75M -116.98% | Avg: $192.89M Low: $192.26M High: $193.53M avg. 821.11% | Avg: $204.43M Low: $202.74M High: $207.27M avg. 5.98% | ||
EPS
% change YoY
| $2.27 N/A | -$0.13 -105.72% | -$14.43 -10999.99% | Avg: $0.65 Low: -$0.35 High: $1.24 avg. 104.52% | Avg: $1.64 Low: $0.96 High: $2.31 avg. 150.25% | ||
Operating Expenses
% change YoY
| $322.82M N/A | $415.23M 28.62% | $586.89M 41.34% | Avg: $318.63M Low: $317.58M High: $319.68M avg. -45.70% | Avg: $337.70M Low: $334.90M High: $342.39M avg. 5.98% | ||
FAQ
What is ModivCare stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 78.49% in 2025-2026.
We have gathered data from 3 analysts. Their low estimate is -4.96M, average is 16.32M and high is 17.57M.
What is ModivCare stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 8.41% in 2025-2026.
We have gathered data from 4 analysts. Their low revenue estimate is $3.03B, average is $3.04B and high is $3.05B.
What is ModivCare stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 127.39% in 2025-2026.
We have gathered data from 3 analysts. Their low earnings per share estimate is -$0.35, average is $0.65 and high is $1.24.
What is the best performing analyst?
In the last twelve months analysts have been covering ModivCare stock. The most successful analyst is Brooks O’Neil.